Email Use Example: Graphic Designer to create a simple logo to be used across multiple platforms.

Email Use Example: Graphic Designer to create a simple logo to be used across multiple platforms.

imageGraphic Designer to create a simple logo to be used across multiple platforms.
Logo for real estate using my name, preferably in one or two colors
The delivered product will be used for the following products and will need to be formatted for the uses:
Email header with my picture which will require photoshopping
Email Signature
Marketing flyers in two sizes
Includes a social media banner
I will provide more details as necessary ( 0 comentarios ) Clifton, United States Nº del proyecto: #18723357 ¡Ofrécete a trabajar en este proyecto ahora! El proceso de oferta termina en 6 días. Abierto – quedan 6 días Tu oferta para este trabajo USD Establece tu presupuesto y plazo Describe tu propuesta Consigue pago por tu trabajo Es gratis registrarse y ofertar en los trabajos 38 freelancers están ofertando el promedio de $90 para este trabajo We have an agile and talented graphic design team, capable of designing exclusive premium logos and all printing materials. We can design awesome logo for your real estate firm, Please message me. http://logodesign Más $40 USD en 1 día (2991 comentarios) Dear Client, Hope you will be enjoying a good health. After thoroughly reading your project brief, we hereby offer you our high quality professional services. ABOUT US: We are a team of highly qualified, ex Más $94 USD en 1 día (623 comentarios) Hello! I’m Isuru. I can create a simple logo to be used across multiple platforms as per your preferences .

I run this as “ExpertART” because I provide services quickly & quality designs as much as I can. * Do you ha Más $45 USD en 1 día (1938 comentarios) Hi I have read your details posted in “Create a simple logo” project.

I saw that you need use across multiple platforms. I will Provide you Best quality work with Great Options in Fair price and less time dependi Más $32 USD en 1 día (1063 comentarios) 1: 4-6 Initial Logo Design Concepts within 24 hours. 2: Unlimited Revisions with quick turnaround. 3: Deliverable Format (Web & Print): .AI, .PNG, .

EPS, PDF, PSD, .JPG. OUR PORTFOLIO: [login to view URL] Más $100 USD en 3 días (617 comentarios) HELLO, I have read though your job description and understand that you want graphic quality’logo design . I can do it and ready to start work immediately. The design provided will be creative and according to y Más $33 USD en 0 días (671 comentarios) I have completed more than 1000 projects on I am senior graphic designer with 7 years of experience in graphic design. I have good English communication skill also.

I will design clean and profession Más $50 USD en 1 día (1032 comentarios) Hello Sir , Exxarts Designer is ready to design Logo & Graphics For Real Estate Business. PORTFOLIO LINKS: Please check our logo portfolio: [login to view URL]@N04/albums/72157679156520981 http Más $150 USD en 3 días (1382 comentarios) Hi! I have reviewed your complete description that you need a logo design and I’m very much confident to reach your expectations and give you 100% satisfaction and quality work. Please visit my portfolio to check Más $32 USD en 1 día (548 comentarios) Dear client, Hope you will be enjoying day-by-day growth and opportunities for your business. After reading your project brief, we are going to offer you a diversified suite of services, as we are a team of highly-qua Más $250 USD en 2 días (138 comentarios) Thanks for Reviewing my Bid.I am an experienced graphic designer I can provide you the best quality service to design a LOGO,FLYER,BROCHURE,T-SHIRT,STATIONARY,POSTER, ICON DESIGN, BANNER,ADs DESIGN,WEBSITE DESIGN a Más $194 USD en 0 días (322 comentarios) Hi Boss! Your requirement: We are glad to know that you are looking for Graphic Design Services. Commitment: We will deliver On time, On budget With 100% completion.

Looking forward to your response. We prefe Más $50 USD en 1 día (69 comentarios) designsmaker0 Hi, I can do it. I am an expert in this field. I am here to help you so please message me once. I will give you a draft within 1 to 2 hours. I believe passionately in the power of a well-executed Creative Concept.

Más $30 USD en 0 días (503 comentarios) Hello! Thank you for a job opportunity! I have read the project description and i understood that you need help with designing your logo. I’m very passionate about making great designs, have very good skills in Ado Más $30 USD en 1 día (389 comentarios) Hi, Thanks for the job posting!! I would request kindly have a look at my work portfolio: https://www.freelancer.

com/u/AttrayantDesign.html I will design you a stunning, eye catchy, showy yet profess Más $50 USD en 1 día (177 comentarios) Hey there, what’s up! I’m ready to create brainstorm ideas for your logo we always maintain Logo Design Principal, Color Theory, Typography, Visual Interaction for remarkable Logo. “A Picture is worth a thousand word Más $50 USD en 0 días (556 comentarios) Hi, my name is Carlos, I’m a graphic designer and professional illustrator. I live in Caracas-Venezuela, let me say hello and offer you my services to carry out your project, since it is interesting and adapts to my kn Más $200 USD en 2 días (23 comentarios) Hello, Hope you doing well. I AM Creative & Experienced logo/graphic designer . I AM ready for your logo design immediately and ready to show you the draft with 4 unique concepts with in one business day. please go Más $30 USD en 0 días (154 comentarios) Hello sir, I gone through your project you want to design a logo.

Please come to chat to discuss more. I will give you the best [login to view URL] check my Portfolio –> https://www.freelancer.

com/u/sauravT . Hope I will ge Más $33 USD en 1 día (181 comentarios) phthai Hi there. I am willing to help you with creating an eye-catching and professional logo for your real estate business using your name and in one or two colors as required. It will be made in vector for use on any platfo Más $113 USD en 3 días (120 comentarios) ¡Ofrécete a trabajar en este proyecto ahora! El proceso de oferta termina en 6 días. Abierto – quedan 6 días Tu oferta para este trabajo USD. […]

Read More

Email Use Example: 5 Super-Actionable Facebook Messenger Marketing Tactics to Try Today

Email Use Example: 5 Super-Actionable Facebook Messenger Marketing Tactics to Try Today

imageBy Larry Kim
Aimclear loves making space on our blog for contributed posts from our friends, partners and competitors in the marketing landscape. There are so many brilliant marketers we admire and with whom we interact on our travels around the world.
This week, we open the door to the venerable Larry Kim, whose latest endeavor – MobileMonkey – is challenging boundaries in marketing (as we’d expect Larry to do).
With so much changing seemingly daily in digital marketing, Larry has some innovative ideas to tap Facebook Messenger as a powerful social marketing tool. Read on for Larry’s post!
By Larry Kim
Facebook advertisers have been watching the cost of ads climb over the last few years.
Then the organic Facebook News Feed algorithm update happened in 2018 and the cost of ads skyrocketed.
2018 saw CPMs rise upwards of 122% year over year in some instances.

Advertisers have been forced to think a lot smarter about how they approach social advertising.
Facebook marketers who work in the organic space are also feeling the pain of the News Feed algo update with organic reach in the 0-1% range. I know my friends at Aimclear have written about Facebook’s organic challenges at great length.

Simply put, Facebook knows the value of its feed and they are not going to just give that prime real estate to brands. It’s now pay-for-play to get in the audience’s feed.
If you’re wondering if there are innovative ways to re-think aspects of your social advertising, particularly on Facebook, the answer is yes.
And the answer may well be to look at Facebook Messenger.
Here are 5 tactics you can implement today to increase Facebook organic reach and decrease Facebook ad CPAs: Run Facebook ads with the messages objective Chat blast — like email blasting in Facebook Messenger Send automated Messenger drip campaigns Use Facebook post auto responders Enable a Messenger chatbot as your website chat 1. Facebook Messenger Ads
Messenger can be a powerful way to put a new twist on a standard approach to Facebook marketing.

For the purposes of this argument, I’ve stopped running Facebook ads except with the messages objective.
It’s purely for financial reasons. The cost per result for messages can be a fraction of other traditional Facebook ad objectives like traffic or engagement.
This activates the ability for the business to send future messages with mobile push notifications. Keep in mind, as marketers, we need to continually find ways to legitimately and ethically follow our audiences around the digital universe.

The leads a business gets from a messages ad have an advantage over those from a lead ad because of the magic of chatbot automation.
The business can follow-up immediately with new leads by programming responses delivered by a Messenger chatbot.
Here’s a Facebook Messenger ad campaign case study to illustrate.

We’ve been running these messenger campaigns and, in some instances, are paying only $3 or $4 for contacts.
We automatically follow-up with the leads on Messenger with automated drip campaigns (more on Facebook Messenger drip campaigns in a little bit).
When we were running Facebook campaigns sending visitors to our website, we were paying $3 or $4 per click. At that rate, and our 2% website conversion rate, it cost about $150 for each lead.
Talk about an ad hack! 2. Chat Blasting
The chat blast is the new and improved email blast.
Whatever you send via email marketing can be delivered via Facebook Messenger. While not everyone is active on Messenger, it is a preferred channel for a significant portion of the Facebook user population.

The only difference is you don’t have to worry about spam filters or the promotions tab.
Add push notifications, and we’ve seen instances where brands see 80% open rates using Facebook Messenger.
How does that compete with your current Facebook organic post reach? 3. Drip Campaigns
Drip campaigns are excellent for nurturing customer relationships, especially when your product or service requires onboarding or has a learning curve.

Like email blasting, drip campaigns are another example of a marketing tactic that’s traditionally done through email.
So you can stick with email and its 4% average click-through rate…
Or you can start delivering drip campaigns on Facebook Messenger, where click-through rate can hit a whopping 20% .
Building drip campaign automations for Facebook Messenger is a process similar to what you do with email but you can expect to get a lot better return. 4.

Comment Autoresponders
Comment autoresponders are another Facebook Messenger marketing tactic involving a chatbot.
It’s fairly straightforward to set up a Messenger chatbot to automatically respond to a user who leaves a comment on a organic Facebook post.

When a Facebook user replies to the chatbot autoresponder, they become a Messenger contact (hint: you can now send follow-up messaging to them).
A comment guard is one of the best ways to grow your contacts.
Comment guards, naturally, perform well on posts that are sure to generate a lot of comments.

Leave a comment on this post and see a comment guard in action. 5. Website Chat Widget
Traditional website chat is a great conversion booster.

People who message your website chat are 6x more likely to convert than those who don’t.

But the pay-off can be even better when you use a Facebook Messenger bot as your website chat.
When your website chat is powered by a Messenger bot, everyone who messages your site becomes a contact that you can follow up with.
Automation via bots drives value for the business AND the user. The user can get answers to FAQs instantly, with no queue or wait time. The business gets the contact info of a new lead they can continue to nurture.

Also, it’s important to note that a live operator can take over the chat at any time.
No longer are visitors anonymous, nor does the chat history vanish as soon as the conversation ends.

You can also use your chatbot builder to send follow-up messages after the fact.
With a website chat widget powered by a Facebook Messenger chatbot, the conversations turn from dead ends to leads, and are now also available as a WordPress chat-plugin . Getting Ahead by Starting Facebook Messenger Marketing Now
As digital marketers, we all need to continually explore new avenues to reach captive audiences via social channels. Chatbots may or may not be the answer for your particular brand, but are worth exploring as part of an integrated digital marketing strategy.

Facebook marketers and advertisers: consider the power of automation and the reach, engagement and cost efficiencies that come with chatbots in 2019. Facebook advertising presents huge opportunity for brands to connect with audiences in what seems much more like a 1:1 relationship. Done well, FB advertising – combined with chatbots – can boost your performance and enhance the audience’s perceived connection with your brand through a personalized interaction.

If you have any questions, I’d love to answer them and tell you all the Facebook Messenger marketing hacks I’ve learned in the last year building MobileMonkey.

Join the Conversation Your email address will not be published. Required fields are marked * Share this Post. […]

Read More

Email Use Example: Red Bull und Shure präsentieren „Soundscapes“:

Email Print Share
Shure und Red Bull gehen eine exklusive globale Partnerschaft ein, bei der die Tonaufnahmen von Live-Events in ein aufregendes musikalisches Abenteuer verwandelt werden. Ende 2018 haben Shure und Red Bull drei aufstrebende Musikproduzenten mit dem brandneuen MV88+ Video Kit ausgerüstet, um die Geräuschkulisse bei drei der aufsehenerregendsten Sportevents von Red Bull aufzunehmen. Das Ergebnis ist „Soundscapes“ – genial komponierte Audiotracks, die hier abrufbar sind.
„Der Sound wird bei Sportveranstaltungen oft als Selbstverständlichkeit betrachtet oder spielt nur eine untergeordnete Rolle.

Wenn man jedoch darüber nachdenkt, wären Aufnahmen von Live-Events nichts ohne den entsprechenden Ton – Schlittschuhfahrer, die mit Rekordgeschwindigkeit über die Strecke rasen, das jubelnde Publikum, das Ausweichen in Sekundenschnelle, die Schritte, das Ächzen, die Sprünge und Stürze. Das sind die Momente, die das Erlebnis wirklich aufregend machen“, so Paul Crognale, Manager of Global Marketing, Musician and Consumer Audio bei Shure. „Es ist offensichtlich, dass eine hohe Audioqualität bei Sportevents enorm wichtig ist, gleichzeitig können Aufnahmen unter derartigen Bedingungen schon eine gewisse Herausforderung darstellen. Durch diese Kampagne und die Partnerschaft mit Red Bull können wir diese einmaligen Erlebnisse mit dem MV88+ Video Kit zu neuem Leben erwecken.

Das MV88+ Video Kit, das neueste Produkt in der preisgekrönten MOTIV™ Serie von Digitalmikrofonen und tragbaren Aufnahmelösungen, wurde von den drei Produzenten für das Recording genutzt. Die Produzenten haben die Komplettlösung eingesetzt, um mobil Audioinhalte in professioneller Qualität aufzunehmen. So werden die drei Events von Red Bull zu mehr als einem rein visuellen Vergnügen. Die extrem realistischen Audioaufnahmen fesseln die Zuhörer und versetzen sie direkt an den Veranstaltungsort. So können sie die aufregenden Aspekte der Events sehen, fühlen und hören. Das MV88+ Video Kit verfügt über ein Manfrotto® PIXI Mini-Stativ, eine Smartphonehalterung sowie iOS- und USB-C-Kabel, um eine hohe Kompatibilität und Konnektivität zu gewährleisten.

Die Produzenten haben auf verschiedenen Erdteilen drei der legendärsten Events von Red Bull besucht, um durch Momentaufnahmen auf der jeweiligen Veranstaltung drei außergewöhnliche Klanglandschaften mit dem MV88+ Video Kit zu erstellen.

DJ Anz von NTS Radio aus Manchester machte den Anfang bei der Red Bull Hardline in Wales und nahm die Geräusche und die Stimmung bei einem der härtesten Mountainbikerennen der Welt auf. Danach war das Red Bull Air Race in den USA an der Reihe, wo die weltbesten Piloten aufeinandertreffen. Die Produzentin und DJ Shy One aus South London hat die einzigartige Geräuschkulisse aufgenommen, die entsteht, wenn Rennflugzeuge Geschwindigkeiten von über 380 km/h erreichen, und die Spuren zu einem eingängigen Audiotrack gemischt. In Japan machte HAAi, Veranstalterin der Coconut Beats Shows, beim rasantesten Event auf Kufen, dem Red Bull Crashed Ice, Audioaufnahmen. Jeder kann nun hören, wie die Athleten den steilen Start, Hindernisse und Haarnadelkurven bei Geschwindigkeiten von bis zu 80 km/h meisterten.

Weitere Informationen über die Partnerschaft zwischen Shure und Red Bull sowie die drei Audiotracks, die mit dem MV88+ Video Kit erstellt wurden, finden Sie unter www. […]

Read More

Email Use Example: VistaGen Therapeutics Reports Fiscal 2019 Third Quarter Financial Results

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for treating depression and other central nervous system (CNS) diseases and disorders with high unmet need, today reported financial results for its fiscal year 2019 third quarter ended December 31, 2018.
“Building on significant progress last quarter, we entered 2019 with an exciting late-stage pipeline comprised of three new generation CNS drug candidates with rapid-onset potential and an excellent safety and tolerability profile.

With two candidates having already achieved proof-of-concept efficacy and safety in Phase 2 clinical studies and a third with potentially transformative Phase 2 clinical readouts this year, we look forward to executing our clinical and regulatory plans to achieve the stream of milestones we believe will ultimately make a difference for patients and their support systems, as well as our stockholders,” said Shawn Singh, Chief Executive Officer of VistaGen .
Operational Highlights: Fiscal Year 2019 Third Quarter to Date:
Acquired Two First-in-Class, Late-Stage CNS Drug Candidates
Acquired a license for exclusive worldwide rights to develop and commercialize PH94B, potentially a first-in-class, rapid-onset neurosteroid nasal spray administered in microgram doses for social anxiety disorder (SAD), a common social phobia which, according to the U.S.

National Institute of Mental Health (NIMH), affects approximately 7% of Americans. Based on positive results from Phase 2 and pilot Phase 3 efficacy and safety studies of PH94B, the Company is preparing for Phase 3 clinical development of PH94B for SAD. Acquired a license for exclusive worldwide rights to develop and commercialize PH10, potentially a first-in-class, neurosteroid nasal spray administered in microgram doses for major depressive disorder (MDD). Based on positive results of a small exploratory Phase 2a study in MDD in which rapid-onset antidepressant effects were observed without psychological side effects or systemic exposure, the Company is preparing for planned Phase 2b clinical development of PH10 for MDD. Further Advancements in the Development of AV-101
Continued enrollment in ELEVATE, the Company’s Phase 2 clinical study of the efficacy and safety of AV-101 as an oral adjunctive treatment of individuals with MDD who have an inadequate response to current FDA-approved antidepressants (SSRIs or SNRIs).
Announced data from preclinical studies indicating that AV-101 promotes hippocampal neurogenesis, the process by which new neurons are formed in a region of the brain that involves high-level functions such as emotions, memory, and spatial navigation and exploration. Received FDA Fast Track Designation for development of AV-101 as an oral, non-opioid treatment for neuropathic pain. Together with the Fast Track Designation for development of AV-101 for MDD, the Company has now received two Fast Track Designations from the FDA for development of AV-101.

Strengthened Board of Directors and CNS Clinical and Regulatory Advisory Board
Appointed pharmaceutical industry veteran, Ann Cunningham , to the Board of Directors and Corporate Governance and Nominating Committee.
Appointed to its CNS Clinical and Regulatory Advisory Board, Dr. Michael Liebowitz , a Columbia University psychiatrist and former director and founder of the Anxiety Disorders Clinic at the New York State Psychiatric Institute. Dr. Liebowitz developed the Liebowitz Social Anxiety Scale, or LSAS, which is widely-used as a primary outcome measure in SAD clinical studies, as well as for evaluation of SAD in clinical practice. Expanded Intellectual Property Portfolio
Received a patent related to certain methods of production for AV-101 from the Hong Kong Patents Registry Intellectual Property Department.
Received Notices of Allowance from the IP Australia and the Japan Patent Office related to methods of treating depression with AV-101. Financial Results: Fiscal Quarter Ended December 31, 2018:
Net loss attributable to common stockholders for the fiscal quarter ended December 31, 2018 was $7.

5 million, compared to $3.5 million for the fiscal quarter ended December 31, 2017. Net loss incurred during the quarter ended December 31, 2018 included noncash expense of $2.0 million for the Company’s October 2018 exercise of its option to acquire an exclusive worldwide license to develop and commercialize PH10, as well as increased research and development activities relating to the Company’s AV-101 ELEVATE study in MDD and preclinical programs related to the Company’s CNS pipeline.
Research and development expense totaled approximately $5.3 million for the quarter ended December 31, 2018, compared with approximately $1.6 million for the quarter ended December 31, 2017. The period over period increase is primarily attributable to expenses of the ELEVATE study, manufacturing additional supplies of AV-101 for future clinical and preclinical studies, and several additional preclinical initiatives involving the Company’s CNS pipeline, coupled with the $2.

0 million of noncash expense attributable to the Company’s exercise of its option to acquire the exclusive, worldwide license to develop and commercialize PH10.
General and administrative expense was approximately $1.8 million in the fiscal quarter ended December 31, 2018, compared to approximately $1.

3 million in the fiscal quarter ended December 31, 2017, reflecting an increase in noncash stock-based compensation and in investor and public relations initiatives.

At December 31, 2018, the Company had cash and cash equivalents of approximately $6.3 million, compared to approximately $7.8 million at September 30, 2018.
About VistaGen
VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for CNS diseases and disorders with high unmet need.

Each of VistaGen’s CNS pipeline candidates, AV-101, PH10 and PH94B, has potential to provide rapid-onset therapeutic benefits without the psychological and other side effects, safety concerns or inconvenient clinical administration associated with many current and potential new generation medications for CNS diseases and disorders, such as MDD and SAD. Each drug candidate in VistaGen’s pipeline is either currently in or has completed Phase 2 clinical development.

AV-101, an oral NMDA receptor glycine B antagonist, is in Phase 2 development, initially as an adjunctive treatment of MDD. The FDA has granted Fast Track designation for development of AV-101, both as a potential adjunctive treatment of MDD and as a non-opioid treatment for neuropathic pain . PH10 intranasal, a potential first-in-class rapid-onset neuroactive steroid, has completed Phase 2a development and is now being prepared for Phase 2b clinical development for MDD. PH94B intranasal, also a potential first-in-class rapid-onset neuroactive steroid, has completed Phase 2 development and is now being prepared for Phase 3 clinical development as an on-demand PRN treatment of SAD.
For more information, please visit and connect with VistaGen on Twitter , LinkedIn and Facebook .

Forward-Looking Statements
This release contains various statements concerning VistaGen’s future expectations, plans and prospects, including without limitation, our expectations regarding development and commercialization of our drug candidates, including AV-101 for MDD, neuropathic pain and suicidal ideation, PH94B for SAD, and PH10 for MDD, as well as our intellectual property and commercial protection of our drug candidates, all of which constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are neither promises nor guarantees of future performance and are subject to a variety of risks and uncertainties, many of which are beyond our control, and may cause actual results to differ materially from those contemplated in these forward-looking statements. Among these risks is the possibility that (i) we may encounter unexpected adverse events in patients during our clinical development of any product candidate that cause us to discontinue further development, (ii) we may not be able to successfully demonstrate the safety and efficacy of our product candidates at each stage of clinical development, (iii) success in preclinical studies or in early-stage clinical trials may not be repeated or observed in ongoing or future studies, and ongoing or future preclinical and clinical results may not support further development of, or be sufficient to gain regulatory approval to market AV-101, PH94B, and/or PH10, (iv) decisions or actions of regulatory agencies may negatively affect the progress of, and our ability to proceed with, further clinical studies or to obtain marketing approval for our drug candidates, (v) we may not be able to obtain or maintain adequate intellectual property protection and other forms of marketing and data exclusivity for our product candidates, (vi) we may not have access to or be able to secure substantial additional capital to support our operations, including our ongoing clinical development activities; and (vii) we may encounter technical and other unexpected hurdles in the manufacturing and development of any of our product candidates. Certain other risks are more fully discussed in the section entitled “Risk Factors” in our most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q, as well as discussions of potential risks, uncertainties, and other important factors in our other filings with the Securities and Exchange Commission (SEC). Our SEC filings are available on the SEC’s website at .

In addition, any forward-looking statements represent our views only as of the issuance of this release and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements.
Company Contact
Mark A. McPartland
VistaGen Therapeutics Inc.
Phone: +1 (650) 577-3600
Investor Contact
Valter Pinto / Allison Soss
KCSA Strategic Communications
Phone: +1 (212) 896-1254/+1 (212) 896-1267
Media Contact
Caitlin Kasunich / Lisa Lipson
KCSA Strategic Communications
Phone: +1 (212) 896-1241/+1 (508) 843-6428
Email: VistaGen@KCSA.

VISTAGEN THERAPEUTICS Consolidated Balance Sheets (Amounts in dollars, except share amounts) Unaudited December 31, March 31, 2018 2018 ASSETS Current assets: Cash and cash equivalents $ 6,285,300 $ 10,378,300 Prepaid expenses and other current assets 853,800 644,800 Total current assets 7,139,100 11,023,100 Property and equipment, net 334,900 207,400 Security deposits and other assets 47,800 47,800 Total assets $ 7,521,800 $ 11,278,300 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,086,700 $ 1,195,700 Accrued expenses 827,100 206,300 Current notes payable 49,100 53,900 Capital lease obligations 2,900 2,600 Total current liabilities 1,965,800 1,458,500 Non-current liabilities: Accrued dividends on Series B Preferred Stock 3,456,300 2,608,300 Deferred rent liability 399,800 285,600 Capital lease obligations 7,100 9,300 Total non-current liabilities 3,863,200 2,903,200 Total liabilities 5,829,000 4,361,700 Commitments and contingencies Stockholders’ equity: Preferred stock, $0.

001 par value; 10,000,000 shares authorized at December 31, 2018 and March 31, 2018: Series A Preferred, 500,000 shares authorized, issued and outstanding at December 31, 2018 and March 31, 2018 500 500 Series B Preferred; 4,000,000 shares authorized at December 31, 2018 and March 31, 2018; 1,160,240 shares issued and outstanding at December 31, 2018 and March 31, 2018 1,200 1,200 Series C Preferred; 3,000,000 shares authorized at December 31, 2018 and March 31, 2018; 2,318,012 shares issued and outstanding at December 31, 2018 and March 31, 2018 2,300 2,300 Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2018 and March 31, 2018; 31,204,380 and 23,068,280 shares issued and outstanding at December 31, 2018 and March 31, 2018, respectively 31,200 23,100 Additional paid-in capital 181,035,800 167,401,400 Treasury stock, at cost, 135,665 shares of common stock held at December 31, 2018 and March 31, 2018 (3,968,100 ) (3,968,100 ) Accumulated deficit (175,410,100 ) (156,543,800 ) Total stockholders’ equity 1,692,800 6,916,600 Total liabilities and stockholders’ equity $ 7,521,800 $ 11,278,300
VISTAGEN THERAPEUTICS CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS Amounts in Dollars, except share amounts Unaudited Three Months Ended December 31, Nine Months Ended December 31, 2018 2017 2018 2017 Operating expenses: Research and development $ 5,335,500 $ 1,601,800 $ 13,340,300 $ 5,124,600 General and administrative 1,856,800 1,266,000 5,494,100 4,997,400 Total operating expenses 7,192,300 2,867,800 18,834,400 10,122,000 Loss from operations (7,192,300 ) (2,867,800 ) (18,834,400 ) (10,122,000 ) Other expenses, net: Interest expense, net (1,800 ) (2,000 ) (6,800 ) (7,700 ) Loss on extinguishment of accounts payable (22,700 ) (135,000 ) (22,700 ) (135,000 ) Loss before income taxes (7,216,800 ) (3,004,800 ) (18,863,900 ) (10,264,700 ) Income taxes – – (2,400 ) (2,400 ) Net loss and comprehensive loss (7,216,800 ) (3,004,800 ) (18,866,300 ) (10,267,100 ) Accrued dividend on Series B Preferred stock (290,900 ) (263,000 ) (848,000 ) (766,600 ) Deemed dividend from trigger of down round provision feature – (199,200 ) – (199,200 ) Net loss attributable to common stockholders $ (7,507,700 ) $ (3,467,000 ) $ (19,714,300 ) $ (11,232,900 ) Basic and diluted net loss attributable to common stockholders per common share $ (0.24 ) $ (0.25 ) $ (0.

75 ) $ (1.03 ) Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 30,696,312 13,895,642 26,418,440 10,947,556.


Read More

Email Use Example: Top 6 Văn phòng dịch thuật tốt nhất tại Gia Lai | 73029

Top 6 Văn phòng dịch thuật tốt nhất tại Gia Lai
Dịch thuật bao gồm hai hoạt động chính: biên dịch (hay còn gọi là dịch viết, dịch văn bản, dịch phần mềm; những người đảm trách công việc trong lĩnh vực này còn được gọi là biên dịch viên hoặc dịch giả) và Phiên dịch (hoạt động trong lĩnh vực dịch thuật tại hiện trường theo hình thức dịch nói, dịch cabin. Những người đảm trách công việc này thường được gọi là phiên dịch viên). Dù hoạt động trong lĩnh vực biên dịch hay phiên dịch, họ đều là cầu nối tích cực thúc đẩy quá trình hội nhập, toàn cầu hóa của cá nhân hay doanh nghiệp tại Gia Lai thông qua việc truyền tải, xóa bỏ rào cản ngôn ngữ.
Những năm gần đây nhu cầu dịch thuật công chứng hồ sơ từ tiếng Việt sang tiếng nước ngoài và ngược lại đang gia tăng do nhu cầu du học, du lịch, xuất khẩu lao động trên địa bàn Gia Lai. Việc lựa chọn đơn vị dịch thuật nào uy tín, giá thành cạnh tranh, thời gian giao tài liệu nhanh, phương thức thanh toán linh động là điều không hề đơn giản.

Trong trường hợp này lựa chọn dịch vụ dịch thuật công chứng tại Gia Lai.

Hãy cùng chúng tôi điểm danh 6 Văn phòng dịch thuật uy tín nhất tại Gia Lai Nhé

Văn phòng dịch thuật tại Gia Lai, Công ty dịch thuật miền trung
Công ty dịch thuật tại miền trung là thương hiệu dịch thuật hàng đầu Việt Nam, quy tụ nhiều biên dịch viên, phiên dịch viên hàng đầu trong các lĩnh vực: Dịch thuật tiếng Anh, tiếng Pháp, tiếng Đức, tiếng Nga, tiếng Nhật, tiếng Trung Quốc, tiếng Hàn Quốc, tiếng Thái Lan, tiếng Lào.. vv. Đội ngũ biên dịch viên, phiên dịch viên của Công ty dịch thuật miền trung là những người được đào tạo bài bản, chuyên nghiệp về kiến thức, cũng như kỹ năng của một biên dịch viên – phiên dịch viên chuyên nghiệp, chuyên dịch thuật các dự án trọng điểm tại Gia Lai có nguồn vốn Quốc tế như: ADB, WB, JICA chuyên cung cấp dịch vụ dịch thuật công chứng, dịch chuyên ngành tại TP Pleiku, An Khê, Ayun Pa, Chư Păh, Chư Prông, Chư Pưh, Chư Sê, Đắk Đoa, Đak Pơ, Đức Cơ, Ia Grai, Ia Pa K’Bang, Kông Chro, Krông Pa, Mang Yang, Phú Thiện.

Nhận Phiên dịch, dịch thuật hồ sơ thầu, hợp đồng kinh tế, báo cáo tài chính, hồ sơ cá nhân xin việc, hồ sơ xin VISA từ tiếng Việt sang tiếng nước ngoài hoặc ngược lại. Cung cấp dịch vụ công chứng bản dịch và hợp pháp hóa lãnh sự hồ sơ cho các tổ chức, cá nhân có nhu cầu. Hotline: 0947.688.

883 – 0963.918.

438 Email: . … bản dịch được công chứng pháp lý và có giá trị trên toàn lãnh thổ Việt Nam, 100% được chấp nhận khi xin hồ sơ VISA.

Cam kết, dịch chuẩn xác, giá cạnh tranh.
Hotline: 0947.688.883 – 0963.

Website: http://dichthuatmientrung.
2. Văn phòng dịch thuật tại Gia Lai – Dịch thuật chuyên nghiệp MIDtrans
Được thành lập từ năm 2009, Công ty dịch thuật chuyên nghiệp MIDtrans là một trong những công ty đầu Được thành lập từ năm 2009, Công ty dịch thuật chuyên nghiệp MIDtrans là một trong những công ty đầu tiên cung cấp dịch vụ dịch thuật tại Gia Lai cho các tổ chức uy tín trên địa bàn: Tập đoàn HAGL, CÔNG TY CỔ PHẦN BÒ THỊT – BÒ SỮA CAO NGUYÊN, CÔNG TY TNHH SẢN XUẤT THƯƠNG MẠI DỊCH VỤ TRUNG VIỆT TIẾN,CÔNG TY TNHH THƯƠNG MẠI DỊCH VỤ XÂY DỰNG BÙI GIA GIA LAI,Sở KHĐT tỉnh Gia Lai. Các dự án đã triển khai của Công ty chúng tôi đều được Khách hàng đánh giá cao và đạt được sự tín nhiệm về chất lượng biên phiên dịch, Đó là kết quả của một hệ thống quản lý chất lượng dịch thuật chuyên nghiệp, những tâm huyết và kinh nghiệm biên phiên dịch nhiều năm của đội ngũ dịch giả dịch ngôn ngữ khác theo yêu cầu của khách hàng.

3. Văn phòng dịch thuật tại Gia Lai – Công ty dịc thuật sài gòn 247
Hồ sơ dịch tại dịch thuật sài gòn 247 được dịch bởi các chuyên gia dịch thuật hàng đầu có chuyên môn sâu và kinh nghiệm trong lĩnh vực dịch thuật, được dịch thuật công chứng tại Bạc Liêu bởi một cơ quan pháp lý có trách nhiệm và có giá trị sử dụng trên toàn lãnh thổ Việt Nam.

Trường hợp khách hàng cần hợp pháp hóa lãnh sự cho bộ tài liệu để đem sang nước ngoài, chúng tôi sẽ cung cấp thêm dịch vụ này cho khách hàng với chi phí phải chăng, tránh lãng phí cho Khách hàng trong quá trình thực chuẩn bị hồ sơ. DTSG 247 áp dụng quy trình dịch thuật khép kín và khoa học, đảm bảo chất lượng cao nhất, giá cả hợp lý, luôn lắng nghe và tiếp thu ý kiến của khách hàng trước và trong quá trình biên dịch, chỉnh sửa và hiệu đính để có được bản dịch cuối cùng tốt nhất. Ngoài dịch văn bản, Công ty dịch thuật Sài Gòn còn cung cấp phiên dịch viên/thông dịch viên cao cấp cho các hội nghị, hội thảo, điều tra thị trường, lắp đặt kỹ thuật…trong ngắn hạn và dài hạn trên 50 ngôn ngữ quốc tế và 58 chuyên ngành như tiếng Anh, Pháp, Nga, Nhật, Trung, Hàn, Tây Ban Nha, Ý, Lào, Campuchia, Thụy Điển, Myanmar, Brasil, Ả rập, Hungary, Hà Lan, Myanmar, Philippin…
4. Dịch thuật Đà Nẵng MIDtrans, Văn phòng dịch thuật tại Gia Lai
Dịch thuật Pro có hơn 30 nhân viên biên dịch có nhiều kinh nghiệm dịch thuật đa chuyên ngành như: Công nghệ thông tin, y khoa, y dược, y học, hóa chất, dược phẩm, cơ khí, ô tô , kỹ thuật công trình xây dựng, kỹ thuật công trình xây dựng, điện, điện tử, tờ rơi, email marketing, bài PR, nội dung marketing, nhãn mác, nhãn sản phẩm, website công ty. Với đội ngũ dịch tài liệu đa ngôn ngữ đầy kinh nghiệm và tác phong chuyên nghiệp, bản dịch tài liệu các ngôn ngữ nước ngoài sẽ được chuyển hóa sang ngôn ngữ gốc một cách uyển chuyển về ngôn từ, sâu sắc trong cách diễn đạt và chính xác trong thuật ngữ sẽ giúp cho khách hàng hài lòng với độ chính xác từng thuật ngữ, từng nội dung.
Email: info@dichthuatmientrung.
5. Dong Thap Translation – Công ty dịch thuật Viettrans
Viettrans provides multilingual translation in Gia Lai: English, Chinese, French, Japanese, Korean, German, Russian, Spanish, Portuguese, Italian, Dutch, Arabic Czech Republic, Sweden, Denmark, Poland, Latin America, Hungary, Bulgaria, Slovakia, Ukraine, Laos, Cambodia, Thailand, Myanmar, Philippines, Indonesia, Malaysia
Notarized translation service: Certificate of seal registration, Bank statements, VAT returns, Bachelor’s degree, Secondary school diploma, High school certificates, Certificates, School records, Student ID card, Driving license, People’s identity card, Retirement certificate, Marriage certificate, Birth certificate, Judicial Records, Social insurance book, Land use certificate and many other papers required by customers.
6. Văn Phòng tại Gia Lai, Công ty dịch thuật và phiên dịch Sài Gòn
Công ty dịch thuật, Phiên dịch Sài Gòn là công ty dịch thuật phiên dịch được thành lập từ 2009 bởi các nhà Quản Trị có tầm, có tâm cùng đội ngũ biên dịch viên được đào tạo bài bản, hiểu biết về nhiều chuyên ngành chuyên biệt.

Quan điểm của chúng tôi là sự thành công của khách hàng chính là sự thành công của chúng tôi. Lấy sứ mệnh phục vụ khách hàng làm mục tiêu hoạt động, chúng tôi luôn nỗ lực nhằm mang đến khách hàng các dịch vụ tương xứng với chi phí mà khách hàng đã chi trả khi sử dụng dịch vụ của chúng tôi. Xem thêm các thông tin của chúng tôi
Các dịch vụ cơ bản của Văn phòng dịch thuật tại Gia Lai Bao Gồm:
Dịch thuật đa ngôn ngữ & đa chuyên ngành, Cung cấp phiên dịch đa ngôn ngữ ngắn ngày và dài, Cung cấp dịch vụ hợp pháp hóa lãnh sự trọn gói:
Hotline: 0947.688.

883 – 0963.918.438
Email: dichthuatsaigon247@gmail.

com. […]

Read More